lipoxin a4 has been researched along with Lung Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchanan, PJ; Clarke, DT; Harvey, BJ; Linnane, B; McDermott, M; McNally, P; Millar, RG; Ringholz, FC; Urbach, V | 1 |
| Bahl, CD; Bomberger, JM; Eddens, T; Flitter, BA; Hammock, BD; Hampton, TH; Hvorecny, KL; Kolls, JK; Kwak, DH; Lee, JS; Levy, BD; Liu, X; Madden, DR; Morisseau, C; Ono, E; Yang, J | 1 |
| Bannenberg, G; Bauman, JG; Devchand, PR; Gronert, K; Guilford, WJ; Moussignac, RL; Parkinson, JF; Perez, HD; Schmidt, BA; Serhan, CN; Subramanyam, B | 1 |
| Bodzenta-Lukaszyk, A; Distler, O; Gay, RE; Gay, S; Kowal, K; Kowal-Bielecka, O; Michel, BA; Rojewska, J; Sierakowski, S | 1 |
| Griese, M; Paul, K; Ratjen, F; Rietschel, E; Starosta, V | 1 |
| Jin, SW; Lian, QQ; Liu, D; Wu, P; Yao, SL; Ye, DY; Zhang, L | 1 |
| Brezinski, M; Crea, AE; Gant, V; Lee, TH; Marron, BE; Nicolaou, KC; Reardon, E; Serhan, CN; Spur, BW | 1 |
7 other study(ies) available for lipoxin a4 and Lung Diseases
| Article | Year |
|---|---|
Reduced 15-lipoxygenase 2 and lipoxin A4/leukotriene B4 ratio in children with cystic fibrosis.
Topics: Anti-Bacterial Agents; Arachidonate 15-Lipoxygenase; Bronchoalveolar Lavage Fluid; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Inflammation; Leukotriene A4; Leukotriene B4; Lipoxins; Longitudinal Studies; Lung; Lung Diseases; Macrophages, Alveolar; Male; Neutrophils | 2014 |
Pseudomonas aeruginosa sabotages the generation of host proresolving lipid mediators.
Topics: 8,11,14-Eicosatrienoic Acid; Bacterial Proteins; Bronchoalveolar Lavage Fluid; Cell Line; Crystallography, X-Ray; Cystic Fibrosis; Humans; Inflammation; Lipoxins; Lung Diseases; Neutrophil Activation; Neutrophils; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Virulence Factors | 2017 |
Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration.
Topics: Administration, Oral; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Ear, External; Inflammation; Injections, Intravenous; Lipoxins; Lung Diseases; Male; Mice; Peritonitis; Reperfusion Injury; Zymosan | 2004 |
Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: an imbalance between proinflammatory and antiinflammatory lipid mediators.
Topics: Adult; Aged; Bronchoalveolar Lavage Fluid; Dinoprostone; Eicosanoids; Female; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Lipoxins; Lipoxygenase; Lung Diseases; Male; Middle Aged; Prostaglandin-Endoperoxide Synthases; Respiratory Function Tests; Scleroderma, Systemic | 2005 |
Anti-inflammatory cytokines in cystic fibrosis lung disease.
Topics: Adolescent; Adult; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Child; Child, Preschool; Cystic Fibrosis; Cytokines; Female; Humans; Inflammation Mediators; Lipoxins; Lung Diseases; Male; Uteroglobin | 2006 |
Posttreatment with aspirin-triggered lipoxin A4 analog attenuates lipopolysaccharide-induced acute lung injury in mice: the role of heme oxygenase-1.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Heme Oxygenase-1; Lipopolysaccharides; Lipoxins; Lung Diseases; Male; Mice; Mice, Inbred C57BL; Random Allocation; Time Factors | 2007 |
Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases.
Topics: Adult; Bronchoalveolar Lavage Fluid; Chromatography, High Pressure Liquid; Female; Gas Chromatography-Mass Spectrometry; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Leukotriene E4; Lipoxins; Lung Diseases; Male; Middle Aged; Radioimmunoassay; Sarcoidosis; SRS-A | 1990 |